ADRIAMYCIN METHOTREXATE HIGH-DOSE VERSUS ADRIAMYCIN METHOTREXATE MODERATE DOSE AS ADJUVANT CHEMOTHERAPY FOR OSTEOSARCOMA OF THE EXTREMITIES - A RANDOMIZED STUDY

被引：67

作者：

BACCI, G

GHERLINZONI, F

PICCI, P

VANHORN, JR

JAFFE, N

GUERRA, A

RUGGIERI, P

BIAGINI, R

CAPANNA, R

TONI, A

MERCURI, M

DALLARI, D

CAMPANACCI, M

机构：

[1] UNIV BOLOGNA, IST ORTOPED RIZZOLI, CTR BONE TUMOR, VIA CODIVILLA 9, I-40136 BOLOGNA, ITALY

[2] UNIV BOLOGNA, IST ORTOPED RIZZOLI, ORTHOPAED CLIN 1, I-40136 BOLOGNA, ITALY

[3] ST RADBOUD HOSP, NIJMEGEN, NETHERLANDS

[4] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, HOUSTON, TX 77030 USA

[5] IST ORTOPED RIZZOLI, DEPT INTERNAL MED & ONCOL, BOLOGNA, ITALY

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1986年 / 22卷 / 11期

关键词：

D O I：

10.1016/0277-5379(86)90142-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1337 / 1345

页数：9

共 35 条

[21]

LINK M, 1985, ASCO P C, V924, P237

[22]

MANTEL N, 1959, J NATL CANCER I, V22, P719

[23]

PICCI P, 1982, CHEMIOT ONCOL, V6, P420

[24]

PRATT C, 1977, CANCER-AM CANCER SOC, V39, P51, DOI 10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO

[25]

2-T

[26]

ROSEN G, 1975, CANCER-AM CANCER SOC, V35, P622, DOI 10.1002/1097-0142(197503)35:3<622::AID-CNCR2820350313>3.0.CO

[27]

2-C

[28]

ROSEN G, 1985, ORTHOPEDICS, V8, P659

[29] PRIMARY OSTEOGENIC-SARCOMA - 8-YEAR EXPERIENCE WITH ADJUVANT CHEMOTHERAPY [J].

ROSEN, G ;

MARCOVE, RC ;

HUVOS, AG ;

CAPARROS, BI ;

LANE, JM ;

NIRENBERG, A ;

CACAVIO, A ;

GROSHEN, S .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 106 :55-67

[30]

SUTOW WW, 1975, CANCER-AM CANCER SOC, V36, P1598, DOI 10.1002/1097-0142(197511)36:5<1598::AID-CNCR2820360511>3.0.CO

← 1 2 3 4 →